FibroBiologics(FBLG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FBLG FibroBiologics

休市中 12-20 15:59:59 EST

2.25

+0.22

+10.84%

盘后2.25

+0.000.00%

18:54 EST

最高2.29	最低2.02	成交量22.41万
今开2.03	昨收2.03	日振幅13.30%
总市值7,798万	流通市值5,595万	总股本3,466万
成交额48.60万	换手率0.90%	流通股本2,487万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":2.25,"timestamp":1734728399999,"preClose":2.03,"halted":0,"volume":224053,"hourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.25,"latestTime":"18:54 EST","volume":14685,"amount":33034.2,"timestamp":1734738871059},"delay":0,"floatShares":24865783,"shares":34659125,"eps":-0.566195,"marketStatus":"休市中","marketStatusCode":7,"change":0.22,"latestTime":"12-20 15:59:59 EST","open":2.03,"high":2.29,"low":2.02,"amount":486013.459854,"amplitude":0.133005,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.566195,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1706677200000,"adjPreClose":2.03,"preHourTrading":{"tag":"盘前","latestPrice":2.13,"preClose":2.03,"latestTime":"09:28 EST","volume":4,"amount":8.38,"timestamp":1734704906014},"postHourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.25,"latestTime":"18:54 EST","volume":14685,"amount":33034.2,"timestamp":1734738871059},"volumeRatio":1.810252191338511},"requestUrl":"/m/hq/s/FBLG/tweets","defaultTab":"tweets","newsList":[{"id":"2491713473","title":"Fibrobiologics, Inc.盘中异动 早盘急速下跌5.29%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491713473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491713473?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:08","pubTimestamp":1734102532,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时08分，Fibrobiologics, Inc.股票出现波动，股价快速下挫5.29%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230853a1ec44a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230853a1ec44a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2490382649","title":"Fibrobiologics, Inc.盘中异动 早盘大幅拉升10.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490382649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490382649?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:31","pubTimestamp":1734013894,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时31分，Fibrobiologics, Inc.股票出现异动，股价急速拉升10.94%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223134ab72a80d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223134ab72a80d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2485429322","title":"Fibrobiologics, Inc.盘中异动 早盘大幅上涨5.39%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485429322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485429322?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:18","pubTimestamp":1732292290,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时18分，Fibrobiologics, Inc.股票出现异动，股价大幅上涨5.39%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123001810abd7bee7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123001810abd7bee7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2485149933","title":"Fibrobiologics, Inc.2024财年第三财季实现净利润-500000.00美元，同比增加77.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485149933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485149933?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:00","pubTimestamp":1732118436,"startTime":"0","endTime":"0","summary":"11月21日，Fibrobiologics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-500000.00美元，同比增加77.17%；其中营业收入为0.00美元，每股基本收益为-0.01美元。从资产负债表来看，Fibrobiologics, Inc.总负债7.73百万美元，其中短期债务507000.00美元，资产负债比为1.36，流动比率为1.23。机构评级：截至2024年11月21日，当前有4家机构对Fibrobiologics, Inc.目标价做出预测，其中目标均价为12.75美元，其中最低目标价为11.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000043abd25bd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000043abd25bd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG"],"gpt_icon":0},{"id":"2483688112","title":"Fibrobiologics, Inc.盘中异动 股价大涨6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483688112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483688112?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508318,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Fibrobiologics, Inc.股票出现波动，股价大幅拉升6.47%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223159971a6470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223159971a6470&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2480581808","title":"Fibrobiologics, Inc.盘中异动 急速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581808?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:36","pubTimestamp":1730730981,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时36分，Fibrobiologics, Inc.股票出现波动，股价急速跳水5.03%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422362298e4048d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422362298e4048d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2479036610","title":"Fibrobiologics, Inc.盘中异动 股价大跌5.08%报2.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479036610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479036610?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:14","pubTimestamp":1730384041,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时14分，Fibrobiologics, Inc.股票出现异动，股价快速下跌5.08%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为2.92%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122140198e3fbdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122140198e3fbdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2477552276","title":"Fibrobiologics, Inc.盘中异动 大幅上涨5.12%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477552276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477552276?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:14","pubTimestamp":1729782851,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时14分，Fibrobiologics, Inc.股票出现波动，股价快速上涨5.12%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024231411971a219d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024231411971a219d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2476255302","title":"Fibrobiologics, Inc.盘中异动 早盘大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476255302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476255302?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:53","pubTimestamp":1729259611,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时53分，Fibrobiologics, Inc.股票出现波动，股价大幅上涨5.10%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018215331971a121c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018215331971a121c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2476120886","title":"Fibrobiologics, Inc.盘中异动 早盘快速上涨8.00%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476120886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476120886?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:32","pubTimestamp":1729171933,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时32分，Fibrobiologics, Inc.股票出现波动，股价急速上涨8.00%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721321395afa828&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721321395afa828&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2474741081","title":"Fibrobiologics, Inc.盘中异动 股价大跌6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474741081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474741081?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:51","pubTimestamp":1728568264,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时51分，Fibrobiologics, Inc.股票出现波动，股价急速下挫6.22%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021510498e3bbae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021510498e3bbae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2474461226","title":"Fibrobiologics, Inc.盘中异动 大幅下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474461226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474461226?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:02","pubTimestamp":1728482561,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时02分，Fibrobiologics, Inc.股票出现异动，股价大幅下跌5.09%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100922024198e3b7ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100922024198e3b7ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2472957359","title":"Fibrobiologics, Inc.盘中异动 大幅上涨6.81%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472957359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472957359?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:33","pubTimestamp":1728048826,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时33分，Fibrobiologics, Inc.股票出现异动，股价急速上涨6.81%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004213346ab67bc5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004213346ab67bc5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2468577534","title":"Fibrobiologics, Inc.盘中异动 早盘股价大涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468577534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468577534?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:32","pubTimestamp":1726752768,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时32分，Fibrobiologics, Inc.股票出现波动，股价快速上涨5.86%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注于开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213248956fa366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213248956fa366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2446460568","title":"Fibrobiologics宣布一种新型人工胸腺类器官技术的初步概念证明。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446460568","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446460568?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:31","pubTimestamp":1719322268,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","FBLG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fibrobiologics.com","stockEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0045},{"period":"3month","weight":-0.3182},{"period":"6month","weight":-0.5253},{"period":"1year","weight":-0.7188},{"period":"ytd","weight":-0.7188}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"FibroBiologics, Inc.最初于2021年4月8日根据德克萨斯州法律成立为有限责任公司，然后于2021年12月14日转变为特拉华州公司。FibroBiologics是一家早期细胞治疗公司，总部位于德克萨斯州休斯顿，开发利用成纤维细胞治疗慢性疾病的创新疗法。该公司的主要重点是启动和推进与成纤维细胞治疗退行性椎间盘疾病、多发性硬化症、癌症、伤口愈合和其他疾病相关的临床前研究和临床阶段FDA试验。","exchange":"NASDAQ","name":"FibroBiologics","nameEN":"FibroBiologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FibroBiologics(FBLG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供FibroBiologics(FBLG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"FibroBiologics,FBLG,FibroBiologics股票,FibroBiologics股票老虎,FibroBiologics股票老虎国际,FibroBiologics行情,FibroBiologics股票行情,FibroBiologics股价,FibroBiologics股市,FibroBiologics股票价格,FibroBiologics股票交易,FibroBiologics股票购买,FibroBiologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FibroBiologics(FBLG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供FibroBiologics(FBLG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}